Deal Announcements

BioNano Genomics Bags $5 Million Venture Capital Debt

Tuesday, July 1, 2014 5:30:00 AM PDT | VentureDeal

   San Diego, California  --  Biotechnology company BioNano Genomics has secured $5 million in venture capital debt investment, according to an SEC regulatory filing.

BioNano has developed a new platform that enables researchers to conduct unique DNA studies in ways that current tools "failed to highlight."

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

BioNano is still seeking $1.1 million in additional debt financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1